// App-Quantinova.ai

3730 : Characterization of lincRNA BALIR-6 in MLL rearranged B-lymphoblastic leukemia

Researchers

Presenter

  • Norma Iris Rodriguez-Malave

Principal Investigators

  • Weihong Yan

  • Giuseppe Basso

  • Martina Pigazzi

  • Dinesh S. Rao

Medical Centers

  • Department of Pathology and Laboratory Medicine, Los Angeles, CA

  • Department of Womens and Childrens Health, Laboratory of Oncohematology, University of Padua, Padua, Italy

  • Department of Womens and Childrens Health, IRP- Istituto di Ricerca Pediatrica- Fondazione Citta della Speranza-University of Padova, Padova, Italy

  • Broad Stem Cell Research Center, UCLA, Los Angeles, CA

  • Cellular and Molecular Pathology Ph.D. Program, UCLA, Los Angeles, CA

  • Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA

  • Ph.D.,,,

  • Department of Chemistry and Biochemistry, UCLA, Los Angeles, CA

  • Department of Biology, California Institute of Technology, Pasadena, CA

Locations

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Alpha-methylacyl-CoA racemase

  • Histone-lysine N-methyltransferase 2A

  • Special AT-rich sequence-binding protein-1

Drug/Treatment

  • miR155

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim